{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:05:11Z","timestamp":1795061111810,"version":"4.10.2"},"reference-count":299,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-023-00454-1","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:03:10Z","timestamp":1692853390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":835,"title":["Major depressive disorder"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-8230","authenticated-orcid":false,"given":"Wolfgang","family":"Marx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda W. J. H.","family":"Penninx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-7233","authenticated-orcid":false,"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"454_CR1","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019. Global Burden of Disease Collaborative Network https:\/\/vizhub.healthdata.org\/gbd-results\/ (2021)."},{"key":"454_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3109\/00048674.2011.621060","volume":"45","author":"NJ Reavley","year":"2011","unstructured":"Reavley, N. J. & Jorm, A. F. Recognition of mental disorders and beliefs about treatment and outcome: findings from an Australian national survey of mental health literacy and stigma. Aust. NZ J. Psychiatry 45, 947\u2013956 (2011).","journal-title":"Aust. NZ J. Psychiatry"},{"key":"454_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaac.2020.10.008","volume":"60","author":"A Wickersham","year":"2021","unstructured":"Wickersham, A. et al. Systematic review and meta-analysis: the association between child and adolescent depression and later educational attainment. J. Am. Acad. Child Adolesc. Psychiatry 60, 105\u2013118 (2021).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"454_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/jech-2021-218074","volume":"76","author":"D Campbell","year":"2022","unstructured":"Campbell, D. et al. Effects of depression on employment and social outcomes: a Mendelian randomisation study. J. Epidemiol. Commun. Health 76, 563\u2013571 (2022).","journal-title":"J. Epidemiol. Commun. Health"},{"key":"454_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10826-018-01316-1","volume":"28","author":"K Cheung","year":"2019","unstructured":"Cheung, K. & Theule, J. Paternal depressive symptoms and parenting behaviors: an updated meta-analysis. J. Child Fam. Stud. 28, 613\u2013626 (2019).","journal-title":"J. Child Fam. Stud."},{"key":"454_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00127-018-1521-2","volume":"53","author":"N Mets\u00e4-Simola","year":"2018","unstructured":"Mets\u00e4-Simola, N., Martikainen, P. & Monden, C. W. Psychiatric morbidity and subsequent divorce: a couple-level register-based study in Finland. Soc. Psychiatry Psychiatr. Epidemiol. 53, 823\u2013831 (2018).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"454_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/schbul\/sbt114","volume":"40","author":"D Rasic","year":"2014","unstructured":"Rasic, D., Hajek, T., Alda, M. & Uher, R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. Schizophrenia Bull. 40, 28\u201338 (2014).","journal-title":"Schizophrenia Bull."},{"key":"454_CR8","doi-asserted-by":"publisher","first-page":"13086","DOI":"10.4088\/JCP.15m09936","volume":"78","author":"PJ Havinga","year":"2017","unstructured":"Havinga, P. J. et al. Doomed for disorder? High incidence of mood and anxiety disorders in offspring of depressed and anxious patients: a prospective cohort study. J. Clin. Psychiatry 78, 13086 (2017).","journal-title":"J. Clin. Psychiatry"},{"key":"454_CR9","unstructured":"World Health Organization. World Mental Health Report: Transforming Mental Health for All: Executive Summary (WHO, 2022)."},{"key":"454_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller, A. H. & Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22\u201334 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"454_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker, R. H. & Agam, G. Major depressive disorder. N. Engl. J. Med. 358, 55\u201368 (2008).","journal-title":"N. Engl. J. Med."},{"key":"454_CR12","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (American Psychiatric Association, 2022).","DOI":"10.1176\/appi.books.9780890425787"},{"key":"454_CR13","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems: Alphabetical Index Vol. 3 (WHO, 2004)."},{"key":"454_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2017.1306082","author":"M Bauer","year":"2017","unstructured":"Bauer, M., Severus, E., M\u00f6ller, H. J. & Young, A. H. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines. Int. J. Psychiatry Clin. Pract. https:\/\/doi.org\/10.1080\/13651501.2017.1306082 (2017).","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"454_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/15622975.2022.2112074","volume":"24","author":"W Marx","year":"2022","unstructured":"Marx, W. et al. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce. World J. Biol. Psychiatry 24, 333\u2013386 (2022).","journal-title":"World J. Biol. Psychiatry"},{"key":"454_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","volume":"401","author":"S Marwaha","year":"2023","unstructured":"Marwaha, S. et al. Novel and emerging treatments for major depression. Lancet 401, 141\u2013153 (2023).","journal-title":"Lancet"},{"key":"454_CR17","doi-asserted-by":"publisher","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn, R. S. et al. Schizophrenia. Nat. Rev. Dis. Primers\u00a01, 15067 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"454_CR18","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","volume":"4","author":"E Vieta","year":"2018","unstructured":"Vieta, E. et al. Bipolar disorders. Nat. Rev. Dis. Primers\u00a04, 18008 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"454_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-020-0200-2","volume":"6","author":"SM Gold","year":"2020","unstructured":"Gold, S. M. et al. Comorbid depression in medical diseases. Nat. Rev. Dis. Primers\u00a06, 69 (2020). A detailed disease Primer on the relationship between comorbid depression and non-communicable diseases.","journal-title":"Nat. Rev. Dis. Primers"},{"key":"454_CR20","doi-asserted-by":"crossref","unstructured":"Scott, K. M., de Jonge, P., Stein, D. J. & Kessler, R. C. Mental Disorders Around the World: Facts and Figures from the WHO World Mental Health Surveys (Cambridge Univ. Press, 2018).","DOI":"10.1017\/9781316336168"},{"key":"454_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1017\/S0033291709991036","volume":"40","author":"TE Moffitt","year":"2010","unstructured":"Moffitt, T. E. et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol. Med. 40, 899\u2013909 (2010).","journal-title":"Psychol. Med."},{"key":"454_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1017\/S0033291712001511","volume":"43","author":"A Ferrari","year":"2013","unstructured":"Ferrari, A. et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol. Med. 43, 471\u2013481 (2013).","journal-title":"Psychol. Med."},{"key":"454_CR23","unstructured":"World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates (WHO, 2017)."},{"key":"454_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","volume":"4","author":"C Kuehner","year":"2017","unstructured":"Kuehner, C. Why is depression more common among women than among men? Lancet Psychiatry 4, 146\u2013158 (2017).","journal-title":"Lancet Psychiatry"},{"key":"454_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","volume":"399","author":"H Herrman","year":"2022","unstructured":"Herrman, H. et al. Time for united action on depression: a Lancet\u2013World Psychiatric Association Commission. Lancet 399, 957\u20131022 (2022). Developed by a Lancet\u2013World Psychiatric Association Commission taskforce, this publication provides a highly detailed overview of a wide range of considerations related to depression.","journal-title":"Lancet"},{"key":"454_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi, M. et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol. Psychiatry 27, 281\u2013295 (2022).","journal-title":"Mol. Psychiatry"},{"key":"454_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/acps.12753","volume":"136","author":"M Ten Have","year":"2017","unstructured":"Ten Have, M. et al. Duration of major and minor depressive episodes and associated risk indicators in a psychiatric epidemiological cohort study of the general population. Acta Psychiatr. Scand. 136, 300\u2013312 (2017).","journal-title":"Acta Psychiatr. Scand."},{"key":"454_CR28","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/S0140-6736(19)32521-8","volume":"394","author":"K Adorjan","year":"2019","unstructured":"Adorjan, K. & Falkai, P. Premature mortality, causes of death, and mental disorders. Lancet 394, 1784\u20131786 (2019).","journal-title":"Lancet"},{"key":"454_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD Mental Disorders Collaborators.","year":"2022","unstructured":"GBD Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9, 137\u2013150 (2022).","journal-title":"Lancet Psychiatry"},{"key":"454_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091936","volume":"9","author":"AJ Ferrari","year":"2014","unstructured":"Ferrari, A. J. et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS ONE 9, e91936 (2014).","journal-title":"PLoS ONE"},{"key":"454_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/wps.20128","volume":"13","author":"E Chesney","year":"2014","unstructured":"Chesney, E., Goodwin, G. M. & Fazel, S. Risks of all\u2010cause and suicide mortality in mental disorders: a meta\u2010review. World Psychiatry 13, 153\u2013160 (2014).","journal-title":"World Psychiatry"},{"key":"454_CR32","doi-asserted-by":"publisher","first-page":"190130","DOI":"10.3389\/fpsyt.2021.690130","volume":"12","author":"H Cai","year":"2021","unstructured":"Cai, H. et al. Prevalence of suicidality in major depressive disorder: a systematic review and meta-analysis of comparative studies. Front. Psychiatry 12, 190130 (2021).","journal-title":"Front. Psychiatry"},{"key":"454_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/acps.12826","volume":"137","author":"R Gournellis","year":"2018","unstructured":"Gournellis, R. et al. Psychotic (delusional) depression and suicidal attempts: a systematic review and meta\u2010analysis. Acta Psychiatr. Scand. 137, 18\u201329 (2018).","journal-title":"Acta Psychiatr. Scand."},{"key":"454_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jad.2013.01.004","volume":"147","author":"KI Hawton","year":"2013","unstructured":"Hawton, K. I., Comabella, C. C., Haw, C. & Saunders, K. Risk factors for suicide in individuals with depression: a systematic review. J. Affect. Disord. 147, 17\u201328 (2013).","journal-title":"J. Affect. Disord."},{"key":"454_CR35","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi, G. S. & Mann, J. J. Depression. Lancet 392, 2299\u20132312 (2018).","journal-title":"Lancet"},{"key":"454_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/wps.20852","volume":"20","author":"P Cuijpers","year":"2021","unstructured":"Cuijpers, P., Smit, F. & Furukawa, T. A. Most at\u2010risk individuals will not develop a mental disorder: the limited predictive strength of risk factors. World Psychiatry 20, 224 (2021).","journal-title":"World Psychiatry"},{"key":"454_CR37","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jamapsychiatry.2019.1200","volume":"76","author":"KS Kendler","year":"2019","unstructured":"Kendler, K. S. From many to one to many \u2014 the search for causes of psychiatric illness. JAMA Psychiatry 76, 1085\u20131091 (2019).","journal-title":"JAMA Psychiatry"},{"key":"454_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamapsychiatry.2017.3828","volume":"75","author":"KS Kendler","year":"2018","unstructured":"Kendler, K. S., Ohlsson, H., Sundquist, K. & Sundquist, J. Sources of parent-offspring resemblance for major depression in a national Swedish extended adoption study. JAMA Psychiatry 75, 194\u2013200 (2018).","journal-title":"JAMA Psychiatry"},{"key":"454_CR39","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1176\/appi.ajp.157.10.1552","volume":"157","author":"PF Sullivan","year":"2000","unstructured":"Sullivan, P. F., Neale, M. C. & Kendler, K. S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157, 1552\u20131562 (2000).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343\u2013352 (2019).","journal-title":"Nat. Neurosci."},{"key":"454_CR41","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","volume":"50","author":"NR Wray","year":"2018","unstructured":"Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668\u2013681 (2018).","journal-title":"Nat. Genet."},{"key":"454_CR42","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.biopsych.2019.02.022","volume":"85","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Genome-wide burden of rare short deletions is enriched in major depressive disorder in four cohorts. Biol. Psychiatry 85, 1065\u20131073 (2019).","journal-title":"Biol. Psychiatry"},{"key":"454_CR43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng.3552","volume":"48","author":"A Okbay","year":"2016","unstructured":"Okbay, A. et al. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat. Genet. 48, 624\u2013633 (2016).","journal-title":"Nat. Genet."},{"key":"454_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap8757","author":"V Anttila","year":"2018","unstructured":"Anttila, V. et al. Analysis of shared heritability in common disorders of the brain. Science https:\/\/doi.org\/10.1126\/science.aap8757 (2018).","journal-title":"Science"},{"key":"454_CR45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1176\/appi.ajp.2018.17121383","volume":"175","author":"A Caspi","year":"2018","unstructured":"Caspi, A. & Moffitt, T. E. All for one and one for all: mental disorders in one dimension. Am. J. Psychiatry 175, 831\u2013844 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajmg.b.32807","volume":"183","author":"SP Hagenaars","year":"2020","unstructured":"Hagenaars, S. P. et al. Genetic comorbidity between major depression and cardio\u2010metabolic traits, stratified by age at onset of major depression. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 183, 309\u2013330 (2020).","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"454_CR47","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1017\/S0033291721000441","volume":"51","author":"K Kendall","year":"2021","unstructured":"Kendall, K. et al. The genetic basis of major depression. Psychol. Med. 51, 2217\u20132230 (2021).","journal-title":"Psychol. Med."},{"key":"454_CR48","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/s41380-018-0247-6","volume":"25","author":"KA Aberg","year":"2020","unstructured":"Aberg, K. A. et al. Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples. Mol. Psychiatry 25, 1344\u20131354 (2020).","journal-title":"Mol. Psychiatry"},{"key":"454_CR49","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nn.2270","volume":"12","author":"PO McGowan","year":"2009","unstructured":"McGowan, P. O. et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342\u2013348 (2009).","journal-title":"Nat. Neurosci."},{"key":"454_CR50","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1176\/appi.ajp.2018.17060595","volume":"175","author":"LK Han","year":"2018","unstructured":"Han, L. K. et al. Epigenetic aging in major depressive disorder. Am. J. Psychiatry 175, 774\u2013782 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/pcn.12621","volume":"72","author":"S Uchida","year":"2018","unstructured":"Uchida, S., Yamagata, H., Seki, T. & Watanabe, Y. Epigenetic mechanisms of major depression: targeting neuronal plasticity. Psychiatry Clin. Neurosci. 72, 212\u2013227 (2018).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"454_CR52","first-page":"1489","volume":"21","author":"BW Sahle","year":"2021","unstructured":"Sahle, B. W. et al. The association between adverse childhood experiences and common mental disorders and suicidality: an umbrella review of systematic reviews and meta-analyses. Eur. Child Adolesc. Psychiatry 21, 1489\u20131499 (2021).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"454_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jad.2022.03.069","volume":"307","author":"KN Kidd","year":"2022","unstructured":"Kidd, K. N., Prasad, D., Cunningham, J. E., de Azevedo Cardoso, T. & Frey, B. N. The relationship between parental bonding and mood, anxiety and related disorders in adulthood: a systematic review and meta-analysis. J. Affect. Disord. 307, 221\u2013236 (2022).","journal-title":"J. Affect. Disord."},{"key":"454_CR54","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jad.2021.08.086","volume":"295","author":"SY Struijs","year":"2021","unstructured":"Struijs, S. Y. et al. Psychological risk factors and the course of depression and anxiety disorders: a review of 15 years NESDA research. J. Affect. Disord. 295, 1347\u20131359 (2021).","journal-title":"J. Affect. Disord."},{"key":"454_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2215-0366(20)30569-1","volume":"8","author":"V Warrier","year":"2021","unstructured":"Warrier, V. et al. Gene\u2013environment correlations and causal effects of childhood maltreatment on physical and mental health: a genetically informed approach. Lancet Psychiatry 8, 373\u2013386 (2021).","journal-title":"Lancet Psychiatry"},{"key":"454_CR56","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41562-020-00980-y","volume":"5","author":"FR Wendt","year":"2021","unstructured":"Wendt, F. R. et al. Multivariate genome-wide analysis of education, socioeconomic status and brain phenome. Nat. Hum. Behav. 5, 482\u2013496 (2021).","journal-title":"Nat. Hum. Behav."},{"key":"454_CR57","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/mp.2016.60","volume":"22","author":"L Schmaal","year":"2017","unstructured":"Schmaal, L. et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol. Psychiatry 22, 900\u2013909 (2017).","journal-title":"Mol. Psychiatry"},{"key":"454_CR58","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1038\/s41380-020-0754-0","volume":"26","author":"LK Han","year":"2021","unstructured":"Han, L. K. et al. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. Mol. Psychiatry 26, 5124\u20135139 (2021).","journal-title":"Mol. Psychiatry"},{"key":"454_CR59","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41380-019-0477-2","volume":"25","author":"LS Van Velzen","year":"2020","unstructured":"Van Velzen, L. S. et al. White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group. Mol. Psychiatry 25, 1511\u20131525 (2020).","journal-title":"Mol. Psychiatry"},{"key":"454_CR60","doi-asserted-by":"publisher","first-page":"146546","DOI":"10.1016\/j.brainres.2019.146546","volume":"1727","author":"F Chen","year":"2020","unstructured":"Chen, F. et al. Hippocampal volume and cell number in depression, schizophrenia, and suicide subjects. Brain Res. 1727, 146546 (2020).","journal-title":"Brain Res."},{"key":"454_CR61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jpsychires.2012.10.020","volume":"47","author":"JA Cobb","year":"2013","unstructured":"Cobb, J. A. et al. Hippocampal volume and total cell numbers in major depressive disorder. J. Psychiatr. Res. 47, 299\u2013306 (2013).","journal-title":"J. Psychiatr. Res."},{"key":"454_CR62","doi-asserted-by":"publisher","first-page":"pyv037","DOI":"10.1093\/ijnp\/pyv037","volume":"18","author":"JL Phillips","year":"2015","unstructured":"Phillips, J. L., Batten, L. A., Tremblay, P., Aldosary, F. & Blier, P. A prospective, longitudinal study of the effect of remission on cortical thickness and hippocampal volume in patients with treatment-resistant depression. Int. J. Neuropsychopharmacol. 18, pyv037 (2015).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"454_CR63","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.4088\/JCP.11m06865","volume":"73","author":"JL Phillips","year":"2012","unstructured":"Phillips, J. L., Batten, L. A., Aldosary, F., Tremblay, P. & Blier, P. Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J. Clin. Psychiatry 73, 2102 (2012).","journal-title":"J. Clin. Psychiatry"},{"key":"454_CR64","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries, G. R., Saldana, V. A., Finnstein, J. & Rein, T. Molecular pathways of major depressive disorder converge on the synapse. Mol. Psychiatry 28, 284\u2013297 (2023).","journal-title":"Mol. Psychiatry"},{"key":"454_CR65","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/mp.2015.199","volume":"21","author":"EI Fried","year":"2016","unstructured":"Fried, E. I. & Kievit, R. A. The volumes of subcortical regions in depressed and healthy individuals are strikingly similar: a reinterpretation of the results by Schmaal et al. Mol. Psychiatry 21, 724\u2013725 (2016).","journal-title":"Mol. Psychiatry"},{"key":"454_CR66","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jamapsychiatry.2022.1780","volume":"79","author":"NR Winter","year":"2022","unstructured":"Winter, N. R. et al. Quantifying deviations of brain structure and function in major depressive disorder across neuroimaging modalities. JAMA Psychiatry 79, 879\u2013888 (2022).","journal-title":"JAMA Psychiatry"},{"key":"454_CR67","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41398-020-0842-6","volume":"10","author":"L Schmaal","year":"2020","unstructured":"Schmaal, L. et al. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Transl Psychiatry 10, 172 (2020).","journal-title":"Transl Psychiatry"},{"key":"454_CR68","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biopsych.2021.06.024","volume":"91","author":"AN Goldstein-Piekarski","year":"2022","unstructured":"Goldstein-Piekarski, A. N. et al. Mapping neural circuit biotypes to symptoms and behavioral dimensions of depression and anxiety. Biol. Psychiatry 91, 561\u2013571 (2022).","journal-title":"Biol. Psychiatry"},{"key":"454_CR69","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S2215-0366(15)00579-9","volume":"3","author":"LM Williams","year":"2016","unstructured":"Williams, L. M. Precision psychiatry: a neural circuit taxonomy for depression and anxiety. Lancet Psychiatry 3, 472\u2013480 (2016).","journal-title":"Lancet Psychiatry"},{"key":"454_CR70","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ebiom.2018.09.010","volume":"36","author":"S Tang","year":"2018","unstructured":"Tang, S. et al. Abnormal amygdala resting-state functional connectivity in adults and adolescents with major depressive disorder: a comparative meta-analysis. EBioMedicine 36, 436\u2013445 (2018).","journal-title":"EBioMedicine"},{"key":"454_CR71","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan, E. et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72, 268\u2013275 (2015).","journal-title":"JAMA Psychiatry"},{"key":"454_CR72","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser, R. H., Andrews-Hanna, J. R., Wager, T. D. & Pizzagalli, D. A. Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity. JAMA Psychiatry 72, 603\u2013611 (2015).","journal-title":"JAMA Psychiatry"},{"key":"454_CR73","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1176\/appi.ajp.2019.18111271","volume":"177","author":"LM McTeague","year":"2020","unstructured":"McTeague, L. M. et al. Identification of common neural circuit disruptions in emotional processing across psychiatric disorders. Am. J. Psychiatry 177, 411\u2013421 (2020).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR74","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1073\/pnas.1900390116","volume":"116","author":"C-G Yan","year":"2019","unstructured":"Yan, C.-G. et al. Reduced default mode network functional connectivity in patients with recurrent major depressive disorder. Proc. Natl Acad. Sci. USA 116, 9078\u20139083 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"454_CR75","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.biopsych.2006.09.020","volume":"62","author":"MD Greicius","year":"2007","unstructured":"Greicius, M. D. et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol. Psychiatry 62, 429\u2013437 (2007).","journal-title":"Biol. Psychiatry"},{"key":"454_CR76","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/mp.2013.105","volume":"19","author":"M Molendijk","year":"2014","unstructured":"Molendijk, M. et al. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol. Psychiatry 19, 791\u2013800 (2014).","journal-title":"Mol. Psychiatry"},{"key":"454_CR77","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamapsychiatry.2022.0645","volume":"79","author":"IV Mousten","year":"2022","unstructured":"Mousten, I. V., S\u00f8rensen, N. V., Christensen, R. H. B. & Benros, M. E. Cerebrospinal fluid biomarkers in patients with unipolar depression compared with healthy control individuals: a systematic review and meta-analysis.JAMA Psychiatry 79, 571\u2013581 (2022).","journal-title":"JAMA Psychiatry"},{"key":"454_CR78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41380-018-0036-2","volume":"24","author":"T Toda","year":"2019","unstructured":"Toda, T., Parylak, S. L., Linker, S. B. & Gage, F. H. The role of adult hippocampal neurogenesis in brain health and disease. Mol. Psychiatry 24, 67\u201387 (2019).","journal-title":"Mol. Psychiatry"},{"key":"454_CR79","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/npp.2013.5","volume":"38","author":"M Boldrini","year":"2013","unstructured":"Boldrini, M. et al. Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology 38, 1068\u20131077 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"454_CR80","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.neuropharm.2010.01.012","volume":"58","author":"PJ Lucassen","year":"2010","unstructured":"Lucassen, P. J., Stumpel, M. W., Wang, Q. & Aronica, E. Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients. Neuropharmacology 58, 940\u2013949 (2010).","journal-title":"Neuropharmacology"},{"key":"454_CR81","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.mp.4001791","volume":"11","author":"A Reif","year":"2006","unstructured":"Reif, A. et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol. Psychiatry 11, 514\u2013522 (2006).","journal-title":"Mol. Psychiatry"},{"key":"454_CR82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","volume":"41","author":"Y Shi","year":"2020","unstructured":"Shi, Y., Luan, D., Song, R. & Zhang, Z. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis. Eur. Neuropsychopharmacol. 41, 40\u201351 (2020).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"454_CR83","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli, L. et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805\u2013809 (2003).","journal-title":"Science"},{"key":"454_CR84","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/sj.npp.1301399","volume":"33","author":"KA Holick","year":"2008","unstructured":"Holick, K. A., Lee, D. C., Hen, R. & Dulawa, S. C. Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33, 406\u2013417 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"454_CR85","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.mp.4002104","volume":"13","author":"G Huang","year":"2008","unstructured":"Huang, G., Bannerman, D. & Flint, J. Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB\/cJ mice. Mol. Psychiatry 13, 119\u2013121 (2008).","journal-title":"Mol. Psychiatry"},{"key":"454_CR86","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.biopsych.2008.02.022","volume":"64","author":"A Surget","year":"2008","unstructured":"Surget, A. et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 64, 293\u2013301 (2008).","journal-title":"Biol. Psychiatry"},{"key":"454_CR87","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.conb.2014.08.012","volume":"30","author":"BR Miller","year":"2015","unstructured":"Miller, B. R. & Hen, R. The current state of the neurogenic theory of depression and anxiety. Curr. Opin. Neurobiol. 30, 51\u201358 (2015).","journal-title":"Curr. Opin. Neurobiol."},{"key":"454_CR88","doi-asserted-by":"publisher","first-page":"101983","DOI":"10.1016\/j.ajp.2020.101983","volume":"51","author":"S Luan","year":"2020","unstructured":"Luan, S., Zhou, B., Wu, Q., Wan, H. & Li, H. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: a systematic review and meta-analysis. Asian J. Psychiatry 51, 101983 (2020).","journal-title":"Asian J. Psychiatry"},{"key":"454_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2021.01.051","volume":"283","author":"CH Vinkers","year":"2021","unstructured":"Vinkers, C. H., Kuzminskaite, E., Lamers, F., Giltay, E. J. & Penninx, B. W. An integrated approach to understand biological stress system dysregulation across depressive and anxiety disorders. J. Affect. Disord. 283, 139\u2013146 (2021).","journal-title":"J. Affect. Disord."},{"key":"454_CR90","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.yebeh.2013.10.020","volume":"38","author":"MF Juruena","year":"2014","unstructured":"Juruena, M. F. Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy Behav. 38, 148\u2013159 (2014).","journal-title":"Epilepsy Behav."},{"key":"454_CR91","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2015.07.011","volume":"58","author":"RP Waters","year":"2015","unstructured":"Waters, R. P. et al. Evidence for the role of corticotropin-releasing factor in major depressive disorder. Neurosci. Biobehav. Rev. 58, 63\u201378 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"454_CR92","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","volume":"73","author":"C Stetler","year":"2011","unstructured":"Stetler, C. & Miller, G. E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73, 114\u2013126 (2011).","journal-title":"Psychosom. Med."},{"key":"454_CR93","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.psyneuen.2005.02.010","volume":"30","author":"HM Burke","year":"2005","unstructured":"Burke, H. M., Davis, M. C., Otte, C. & Mohr, D. C. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30, 846\u2013856 (2005).","journal-title":"Psychoneuroendocrinology"},{"key":"454_CR94","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.psyneuen.2010.04.001","volume":"35","author":"U Knorr","year":"2010","unstructured":"Knorr, U., Vinberg, M., Kessing, L. V. & Wetterslev, J. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology 35, 1275\u20131286 (2010).","journal-title":"Psychoneuroendocrinology"},{"key":"454_CR95","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fpsyt.2019.00974","volume":"10","author":"LS Nandam","year":"2020","unstructured":"Nandam, L. S., Brazel, M., Zhou, M. & Jhaveri, D. J. Cortisol and major depressive disorder \u2014 translating findings from humans to animal models and back. Front. Psychiatry 10, 974 (2020).","journal-title":"Front. Psychiatry"},{"key":"454_CR96","doi-asserted-by":"publisher","first-page":"105625","DOI":"10.1016\/j.psyneuen.2021.105625","volume":"136","author":"Z Zajkowska","year":"2021","unstructured":"Zajkowska, Z. et al. Cortisol and development of depression in adolescence and young adulthood\u2013a systematic review and meta-analysis. Psychoneuroendocrinology 136, 105625 (2021).","journal-title":"Psychoneuroendocrinology"},{"key":"454_CR97","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41380-019-0585-z","volume":"25","author":"M Kennis","year":"2020","unstructured":"Kennis, M. et al. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol. Psychiatry 25, 321\u2013338 (2020).","journal-title":"Mol. Psychiatry"},{"key":"454_CR98","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1176\/appi.ajp.2014.13091264","volume":"171","author":"LL Judd","year":"2014","unstructured":"Judd, L. L. et al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am. J. Psychiatry 171, 1045\u20131051 (2014).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR99","doi-asserted-by":"publisher","first-page":"732157","DOI":"10.3389\/fphar.2021.732157","volume":"12","author":"Y Ding","year":"2021","unstructured":"Ding, Y., Wei, Z., Yan, H. & Guo, W. Efficacy of treatments targeting hypothalamic-pituitary-adrenal systems for major depressive disorder: a meta-analysis. Front. Pharmacol. 12, 732157 (2021).","journal-title":"Front. Pharmacol."},{"key":"454_CR100","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2020.19080848","volume":"177","author":"JB Dwyer","year":"2020","unstructured":"Dwyer, J. B. et al. Hormonal treatments for major depressive disorder: state of the art. Am. J. Psychiatry 177, 686\u2013705 (2020).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR101","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo, E. F. et al. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav. Immun. 87, 901\u2013909 (2020).","journal-title":"Brain Behav. Immun."},{"key":"454_CR102","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1038\/s41380-020-00867-4","volume":"26","author":"N Mac Giollabhui","year":"2021","unstructured":"Mac Giollabhui, N., Ng, T. H., Ellman, L. M. & Alloy, L. B. The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression. Mol. Psychiatry 26, 3302\u20133314 (2021).","journal-title":"Mol. Psychiatry"},{"key":"454_CR103","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3389\/fimmu.2019.01696","volume":"10","author":"CH Lee","year":"2019","unstructured":"Lee, C. H. & Giuliani, F. The role of inflammation in depression and fatigue. Front. Immunol. 10, 1696 (2019).","journal-title":"Front. Immunol."},{"key":"454_CR104","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/09540261.2017.1322555","volume":"29","author":"SB Patten","year":"2017","unstructured":"Patten, S. B., Marrie, R. A. & Carta, M. G. Depression in multiple sclerosis. Int. Rev. Psychiatry 29, 463\u2013472 (2017).","journal-title":"Int. Rev. Psychiatry"},{"key":"454_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.274","volume":"7","author":"W Chiu","year":"2017","unstructured":"Chiu, W., Su, Y., Su, K. & Chen, P. Recurrence of depressive disorders after interferon-induced depression. Transl Psychiatry 7, e1026 (2017).","journal-title":"Transl Psychiatry"},{"key":"454_CR106","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3390\/molecules26082368","volume":"26","author":"S Uzzan","year":"2021","unstructured":"Uzzan, S. & Azab, A. N. Anti-TNF-\u03b1 compounds as a treatment for depression. Molecules 26, 2368 (2021).","journal-title":"Molecules"},{"key":"454_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison, C. L. et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70, 31\u201341 (2013).","journal-title":"JAMA Psychiatry"},{"key":"454_CR108","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","volume":"76","author":"RS McIntyre","year":"2019","unstructured":"McIntyre, R. S. et al. Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial. JAMA Psychiatry 76, 783\u2013790 (2019).","journal-title":"JAMA Psychiatry"},{"key":"454_CR109","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/acps.13016","volume":"139","author":"O K\u00f6hler\u2010Forsberg","year":"2019","unstructured":"K\u00f6hler\u2010Forsberg, O. et al. Efficacy of anti\u2010inflammatory treatment on major depressive disorder or depressive symptoms: meta\u2010analysis of clinical trials. Acta Psychiatr. Scand. 139, 404\u2013419 (2019).","journal-title":"Acta Psychiatr. Scand."},{"key":"454_CR110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.euroneuro.2021.07.092","volume":"53","author":"BT Baune","year":"2021","unstructured":"Baune, B. T. et al. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: a 6-week double-blind placebo controlled randomized trial. Eur. Neuropsychopharmacol. 53, 34\u201346 (2021).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"454_CR111","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.30367","volume":"5","author":"J Hellmann-Regen","year":"2022","unstructured":"Hellmann-Regen, J. et al. Effect of minocycline on depressive symptoms in patients with treatment-resistant depression: a randomized clinical trial. JAMA Netw. Open 5, e2230367 (2022).","journal-title":"JAMA Netw. Open"},{"key":"454_CR112","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.02.021","volume":"79","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis. Brain Behav. Immun. 79, 24\u201338 (2019).","journal-title":"Brain Behav. Immun."},{"key":"454_CR113","doi-asserted-by":"publisher","first-page":"113735","DOI":"10.1016\/j.psychres.2021.113735","volume":"297","author":"F Gay","year":"2021","unstructured":"Gay, F., Romeo, B., Martelli, C., Benyamina, A. & Hamdani, N. Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a meta-analysis. Psychiatry Res. 297, 113735 (2021).","journal-title":"Psychiatry Res."},{"key":"454_CR114","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","volume":"10","author":"G Arteaga-Henr\u00edquez","year":"2019","unstructured":"Arteaga-Henr\u00edquez, G. et al. Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium. Front. Psychiatry 10, 458 (2019).","journal-title":"Front. Psychiatry"},{"key":"454_CR115","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache, D., Pariante, C. M. & Mondelli, V. Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav. Immun. 81, 24\u201340 (2019).","journal-title":"Brain Behav. Immun."},{"key":"454_CR116","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0004867418796955","volume":"52","author":"G Morris","year":"2018","unstructured":"Morris, G. et al. Leaky brain in neurological and psychiatric disorders: drivers and consequences. Austr. NZ J. Psychiatry 52, 924\u2013948 (2018).","journal-title":"Austr. NZ J. Psychiatry"},{"key":"454_CR117","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller, A. H., Maletic, V. & Raison, C. L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65, 732\u2013741 (2009).","journal-title":"Biol. Psychiatry"},{"key":"454_CR118","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877\u20132013 (2019). A seminal review of the mechanisms, preclinical evidence and clinical trial data that have investigated the role of the gut\u2013brain axis in psychiatry.","journal-title":"Physiol. Rev."},{"key":"454_CR119","doi-asserted-by":"publisher","first-page":"604179","DOI":"10.3389\/fimmu.2020.604179","volume":"11","author":"A Rutsch","year":"2020","unstructured":"Rutsch, A., Kantsj\u00f6, J. B. & Ronchi, F. The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front. Immunol. 11, 604179 (2020).","journal-title":"Front. Immunol."},{"key":"454_CR120","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz, B., Bazin, T. & Pellissier, S. The vagus nerve at the interface of the microbiota-gut-brain axis. Front. Neurosci. 12, 49 (2018).","journal-title":"Front. Neurosci."},{"key":"454_CR121","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mce.2022.111572","volume":"546","author":"KJ O\u2019Riordan","year":"2022","unstructured":"O\u2019Riordan, K. J. et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol. Cell. Endocrinol. 546, 111572 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"454_CR122","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/FBP.0b013e32836546fc","volume":"24","author":"WR Resende","year":"2013","unstructured":"Resende, W. R. et al. Effects of sodium butyrate in animal models of mania and depression: implications as a new mood stabilizer. Behav. Pharmacol. 24, 569\u2013579 (2013).","journal-title":"Behav. Pharmacol."},{"key":"454_CR123","doi-asserted-by":"publisher","first-page":"pyw020","DOI":"10.1093\/ijnp\/pyw020","volume":"19","author":"P Luczynski","year":"2016","unstructured":"Luczynski, P. et al. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int. J. Neuropsychopharmacol. 19, pyw020 (2016).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"454_CR124","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2012.77","volume":"18","author":"G Clarke","year":"2013","unstructured":"Clarke, G. et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 18, 666\u2013673 (2013).","journal-title":"Mol. Psychiatry"},{"key":"454_CR125","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2016.07.019","volume":"82","author":"JR Kelly","year":"2016","unstructured":"Kelly, J. R. et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J. Psychiatr. Res. 82, 109\u2013118 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"454_CR126","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/mp.2016.44","volume":"21","author":"P Zheng","year":"2016","unstructured":"Zheng, P. et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host\u2019s metabolism. Mol. Psychiatry 21, 786\u2013796 (2016).","journal-title":"Mol. Psychiatry"},{"key":"454_CR127","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41380-022-01456-3","volume":"27","author":"A McGuinness","year":"2022","unstructured":"McGuinness, A. et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol. Psychiatry 27, 1920\u20131935 (2022).","journal-title":"Mol. Psychiatry"},{"key":"454_CR128","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1113\/JP276431","volume":"596","author":"M Van de Wouw","year":"2018","unstructured":"Van de Wouw, M. et al. Short\u2010chain fatty acids: microbial metabolites that alleviate stress\u2010induced brain\u2013gut axis alterations. J. Physiol. 596, 4923\u20134944 (2018).","journal-title":"J. Physiol."},{"key":"454_CR129","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","volume":"587","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin, I. et al. Host variables confound gut microbiota studies of human disease. Nature 587, 448\u2013454 (2020).","journal-title":"Nature"},{"key":"454_CR130","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmaa181","author":"K Berding","year":"2021","unstructured":"Berding, K. et al. Diet and the microbiota\u2013gut\u2013brain axis: sowing the seeds of good mental health. Adv. Nutr. https:\/\/doi.org\/10.1093\/advances\/nmaa181 (2021).","journal-title":"Adv. Nutr."},{"key":"454_CR131","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/07067437221150508","volume":"68","author":"JE Green","year":"2023","unstructured":"Green, J. E. et al. Feasibility, acceptability, and safety of faecal microbiota transplantation in the treatment of major depressive disorder: a pilot randomized controlled trial. Can. J. Psychiatry 68, 315\u2013326 (2023).","journal-title":"Can. J. Psychiatry"},{"key":"454_CR132","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neubiorev.2019.03.023","volume":"102","author":"RT Liu","year":"2019","unstructured":"Liu, R. T., Walsh, R. F. & Sheehan, A. E. Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials. Neurosci. Biobehav. Rev. 102, 13\u201323 (2019).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"454_CR133","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-020-1495-2","volume":"18","author":"DJ Stein","year":"2020","unstructured":"Stein, D. J. et al. Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies. BMC Med. 18, 21 (2020).","journal-title":"BMC Med."},{"key":"454_CR134","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/01.nmd.0000202239.20315.16","volume":"194","author":"M Zimmerman","year":"2006","unstructured":"Zimmerman, M., McGlinchey, J. B., Young, D. & Chelminski, I. Diagnosing major depressive disorder I: a psychometric evaluation of the DSM-IV symptom criteria. J. Nerv. Ment. Dis. 194, 158\u2013163 (2006).","journal-title":"J. Nerv. Ment. Dis."},{"key":"454_CR135","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1017\/S0033291709992157","volume":"40","author":"V Lux","year":"2010","unstructured":"Lux, V. & Kendler, K. S. Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria. Psychol. Med. 40, 1679\u20131690 (2010).","journal-title":"Psychol. Med."},{"key":"454_CR136","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1600-0447.2004.00301.x","volume":"109","author":"P Cuijpers","year":"2004","unstructured":"Cuijpers, P. & Smit, F. Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr. Scand. 109, 325\u2013331 (2004).","journal-title":"Acta Psychiatr. Scand."},{"key":"454_CR137","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jad.2018.08.010","volume":"241","author":"M Tuithof","year":"2018","unstructured":"Tuithof, M. et al. Course of subthreshold depression into a depressive disorder and its risk factors. J. Affect. Disord. 241, 206\u2013215 (2018).","journal-title":"J. Affect. Disord."},{"key":"454_CR138","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jamapsychiatry.2020.4364","volume":"78","author":"E Karyotaki","year":"2021","unstructured":"Karyotaki, E. et al. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry 78, 361\u2013371 (2021).","journal-title":"JAMA Psychiatry"},{"key":"454_CR139","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/wps.20087","volume":"13","author":"BN Cuthbert","year":"2014","unstructured":"Cuthbert, B. N. The RDoC framework: facilitating transition from ICD\/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13, 28\u201335 (2014).","journal-title":"World Psychiatry"},{"key":"454_CR140","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1037\/abn0000258","volume":"126","author":"R Kotov","year":"2017","unstructured":"Kotov, R. et al. The Hierarchical Taxonomy of Psychopathology (HiTOP): a dimensional alternative to traditional nosologies. J. Abnorm. Psychol. 126, 454\u2013477 (2017).","journal-title":"J. Abnorm. Psychol."},{"key":"454_CR141","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/wps.20566","volume":"17","author":"RF Krueger","year":"2018","unstructured":"Krueger, R. F. et al. Progress in achieving quantitative classification of psychopathology. World Psychiatry 17, 282\u2013293 (2018).","journal-title":"World Psychiatry"},{"key":"454_CR142","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/jamapsychiatry.2015.1743","volume":"72","author":"DR Weinberger","year":"2015","unstructured":"Weinberger, D. R., Glick, I. D. & Klein, D. F. Whither research domain criteria (RDoC)?: The good, the bad, and the ugly. JAMA Psychiatry 72, 1161\u20131162 (2015).","journal-title":"JAMA Psychiatry"},{"key":"454_CR143","first-page":"218","volume":"5","author":"CA Ross","year":"2019","unstructured":"Ross, C. A. & Margolis, R. L. Research domain criteria: strengths, weaknesses, and potential alternatives for future psychiatric research. Mol. Neuropsychiatry 5, 218\u2013236 (2019).","journal-title":"Mol. Neuropsychiatry"},{"key":"454_CR144","unstructured":"Cheung, R. Y. M. in Handbook of Assessment in Mindfulness Research (eds Medvedev, O. N., Kr\u00e4geloh, C. U., Siegert, R. J. & Singh, N. N.) (Springer, 2023)."},{"key":"454_CR145","doi-asserted-by":"publisher","first-page":"l1476","DOI":"10.1136\/bmj.l1476","volume":"365","author":"B Levis","year":"2019","unstructured":"Levis, B., Benedetti, A. & Thombs, B. D. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. Br. Med. J. 365, l1476 (2019).","journal-title":"Br. Med. J."},{"key":"454_CR146","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jad.2017.08.060","volume":"225","author":"S El-Den","year":"2018","unstructured":"El-Den, S., Chen, T. F., Gan, Y.-L., Wong, E. & O\u2019Reilly, C. L. The psychometric properties of depression screening tools in primary healthcare settings: a systematic review. J. Affect. Disord. 225, 503\u2013522 (2018).","journal-title":"J. Affect. Disord."},{"key":"454_CR147","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00127-013-0735-6","volume":"49","author":"H Oyama","year":"2014","unstructured":"Oyama, H. & Sakashita, T. Differences in specific depressive symptoms among community-dwelling middle-aged Japanese adults before and after a universal screening intervention. Soc. Psychiatry Psychiatr. Epidemiol. 49, 251\u2013258 (2014).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"454_CR148","unstructured":"UK National Screening Committee. Screening for Depression in Adults. UK National Screening Committee https:\/\/view-health-screening-recommendations.service.gov.uk\/review\/depression-2020\/download-documents\/cover_sheet\/ (2020)."},{"key":"454_CR149","unstructured":"National Institute for Health and Care Excellence. Depression in Adults: Treatment and Management (Update). National Institute for Health and Care Excellence https:\/\/www.nice.org.uk\/guidance\/ng222 (2022)."},{"key":"454_CR150","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1503\/cmaj.130403","volume":"185","author":"M Joffres","year":"2013","unstructured":"Joffres, M. et al. Recommendations on screening for depression in adults. Can. Med. Assoc. J. 185, 775\u2013782 (2013).","journal-title":"Can. Med. Assoc. J."},{"key":"454_CR151","unstructured":"Keshavarz, H. et al. Screening for Depression. McMaster Evidence Review and Synthesis Centre http:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2013\/06\/2013-depression-systematic-review-en.pdf (2012)."},{"key":"454_CR152","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jama.2015.18392","volume":"315","author":"AL Siu","year":"2016","unstructured":"Siu, A. L. et al. Screening for depression in adults: US Preventive Services Task Force recommendation statement. J. Am. Med. Assoc. 315, 380\u2013387 (2016).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR153","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators.","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9, 137\u2013150 (2022). Developed by the Global Burden of Disease Study, this publication provides a detailed analysis of the global burden of mental disorders.","journal-title":"Lancet Psychiatry"},{"key":"454_CR154","first-page":"263","volume":"18","author":"S Porsdam Mann","year":"2016","unstructured":"Porsdam Mann, S., Bradley, V. J. & Sahakian, B. J. Human rights-based approaches to mental health: a review of programs. Health Hum. Rights 18, 263\u2013276 (2016).","journal-title":"Health Hum. Rights"},{"key":"454_CR155","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12888-015-0394-0","volume":"15","author":"A O\u2019Neil","year":"2015","unstructured":"O\u2019Neil, A. et al. A shared framework for the common mental disorders and non-communicable disease: key considerations for disease prevention and control. BMC Psychiatry 15, 15 (2015).","journal-title":"BMC Psychiatry"},{"key":"454_CR156","doi-asserted-by":"publisher","first-page":"101955","DOI":"10.1016\/j.cpr.2020.101955","volume":"83","author":"P Cuijpers","year":"2021","unstructured":"Cuijpers, P. et al. Psychological interventions to prevent the onset of depressive disorders: a meta-analysis of randomized controlled trials. Clin. Psychol. Rev. 83, 101955 (2021).","journal-title":"Clin. Psychol. Rev."},{"key":"454_CR157","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/0022-006X.71.1.3","volume":"71","author":"SH Spence","year":"2003","unstructured":"Spence, S. H., Sheffield, J. K. & Donovan, C. L. Preventing adolescent depression: an evaluation of the problem solving for life program. J. Consult. Clin. Psychol. 71, 3 (2003).","journal-title":"J. Consult. Clin. Psychol."},{"key":"454_CR158","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cpr.2016.10.005","volume":"51","author":"A Werner-Seidler","year":"2017","unstructured":"Werner-Seidler, A., Perry, Y., Calear, A. L., Newby, J. M. & Christensen, H. School-based depression and anxiety prevention programs for young people: a systematic review and meta-analysis. Clin. Psychol. Rev. 51, 30\u201347 (2017).","journal-title":"Clin. Psychol. Rev."},{"key":"454_CR159","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.brat.2010.12.008","volume":"49","author":"EO Arnarson","year":"2011","unstructured":"Arnarson, E. O. & Craighead, W. E. Prevention of depression among Icelandic adolescents: a 12-month follow-up. Behav. Res. Ther. 49, 170\u2013174 (2011).","journal-title":"Behav. Res. Ther."},{"key":"454_CR160","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.brat.2009.03.011","volume":"47","author":"E\u00d6 Arnarson","year":"2009","unstructured":"Arnarson, E. \u00d6. & Craighead, W. E. Prevention of depression among Icelandic adolescents. Behav. Res. Ther. 47, 577\u2013585 (2009).","journal-title":"Behav. Res. Ther."},{"key":"454_CR161","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.beth.2018.11.005","volume":"50","author":"AP Matos","year":"2019","unstructured":"Matos, A. P. et al. Prevention of initial depressive disorders among at-risk Portuguese adolescents. Behav. Ther. 50, 743\u2013754 (2019).","journal-title":"Behav. Ther."},{"key":"454_CR162","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/jamapsychiatry.2020.1214","volume":"77","author":"M Berk","year":"2020","unstructured":"Berk, M. et al. Effect of aspirin vs placebo on the prevention of depression in older people: a randomized clinical trial. JAMA Psychiatry 77, 1012\u20131020 (2020).","journal-title":"JAMA Psychiatry"},{"key":"454_CR163","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1001\/jama.2021.21187","volume":"326","author":"OI Okereke","year":"2021","unstructured":"Okereke, O. I. et al. Effect of long-term supplementation with marine omega-3 fatty acids vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. J. Am. Med. Assoc. 326, 2385\u20132394 (2021).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR164","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2020.10224","volume":"324","author":"OI Okereke","year":"2020","unstructured":"Okereke, O. I. et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. J. Am. Med. Assoc. 324, 471\u2013480 (2020).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR165","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/wps.20773","volume":"19","author":"J Firth","year":"2020","unstructured":"Firth, J. et al. A meta\u2010review of \u201clifestyle psychiatry\u201d: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry 19, 360\u2013380 (2020).","journal-title":"World Psychiatry"},{"key":"454_CR166","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1176\/appi.ps.201300216","volume":"65","author":"CF Reynolds III","year":"2014","unstructured":"Reynolds, C. F. III et al. Early intervention to preempt major depression among older black and white adults. Psychiatr. Serv. 65, 765\u2013773 (2014).","journal-title":"Psychiatr. Serv."},{"key":"454_CR167","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/jama.2019.0556","volume":"321","author":"M Bot","year":"2019","unstructured":"Bot, M. et al. Effect of multinutrient supplementation and food-related behavioral activation therapy on prevention of major depressive disorder among overweight or obese adults with subsyndromal depressive symptoms: the MooDFOOD randomized clinical trial. J. Am. Med. Assoc. 321, 858\u2013868 (2019).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR168","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2014.1001786","author":"M Bauer","year":"2015","unstructured":"Bauer, M. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. World J. Biol. Psychiatry https:\/\/doi.org\/10.3109\/15622975.2014.1001786 (2015).","journal-title":"World J. Biol. Psychiatry"},{"key":"454_CR169","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy, S. H. et al. Canadian Network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. pharmacological treatments. Can. J. Psychiatry 61, 540\u2013560 (2016).","journal-title":"Can. J. Psychiatry"},{"key":"454_CR170","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","volume":"55","author":"GS Malhi","year":"2021","unstructured":"Malhi, G. S. et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust. NZ J. Psychiatry 55, 7\u2013117 (2021).","journal-title":"Aust. NZ J. Psychiatry"},{"key":"454_CR171","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/wps.20771","volume":"19","author":"M Maj","year":"2020","unstructured":"Maj, M. et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry 19, 269\u2013293 (2020).","journal-title":"World Psychiatry"},{"key":"454_CR172","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1741-7015-10-111","volume":"10","author":"CA Macneil","year":"2012","unstructured":"Macneil, C. A., Hasty, M. K., Conus, P. & Berk, M. Is diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice. BMC Med. 10, 111 (2012).","journal-title":"BMC Med."},{"key":"454_CR173","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.2017.5706","volume":"317","author":"RM Kok","year":"2017","unstructured":"Kok, R. M. & Reynolds, C. F. Management of depression in older adults: a review. J. Am. Med. Assoc. 317, 2114\u20132122 (2017).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR174","doi-asserted-by":"publisher","DOI":"10.2196\/15572","volume":"7","author":"RAH Shalaby","year":"2020","unstructured":"Shalaby, R. A. H. & Agyapong, V. I. Peer support in mental health: literature review. JMIR Ment. Health 7, e15572 (2020).","journal-title":"JMIR Ment. Health"},{"key":"454_CR175","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","volume":"291","author":"K Demyttenaere","year":"2004","unstructured":"Demyttenaere, K. et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. J. Am. Med. Assoc. 291, 2581\u20132590 (2004).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR176","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1192\/bjp.bp.116.188078","volume":"210","author":"G Thornicroft","year":"2017","unstructured":"Thornicroft, G. et al. Undertreatment of people with major depressive disorder in 21 countries. Br. J. Psychiatry 210, 119\u2013124 (2017).","journal-title":"Br. J. Psychiatry"},{"key":"454_CR177","unstructured":"World Health Organization. Mental Health Atlas 2020. WHO https:\/\/www.who.int\/publications\/i\/item\/9789240036703 (2021)."},{"key":"454_CR178","unstructured":"World Health Organization. mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-specialized Health Settings: Mental Health Gap Action Programme (mhGAP) (WHO, 2016)."},{"key":"454_CR179","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.21054","volume":"22","author":"DM Ndetei","year":"2023","unstructured":"Ndetei, D. M., Mutiso, V. & Osborn, T. Moving away from the scarcity fallacy: three strategies to reduce the mental health treatment gap in LMICs. World Psychiatry 22, 163 (2023).","journal-title":"World Psychiatry"},{"key":"454_CR180","doi-asserted-by":"publisher","first-page":"262 LP","DOI":"10.1370\/afm.2676","volume":"19","author":"P Cuijpers","year":"2021","unstructured":"Cuijpers, P. et al. Psychologic treatment of depression compared with pharmacotherapy and combined treatment in primary care: a network meta-analysis. Ann. Fam. Med. 19, 262 LP\u2013262270 (2021).","journal-title":"Ann. Fam. Med."},{"key":"454_CR181","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/wps.20906","volume":"20","author":"TA Furukawa","year":"2021","unstructured":"Furukawa, T. A. et al. Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis. World Psychiatry 20, 387\u2013396 (2021).","journal-title":"World Psychiatry"},{"key":"454_CR182","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/wps.20860","volume":"20","author":"P Cuijpers","year":"2021","unstructured":"Cuijpers, P. et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry 20, 283\u2013293 (2021).","journal-title":"World Psychiatry"},{"key":"454_CR183","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S2215-0366(21)00077-8","volume":"8","author":"TA Furukawa","year":"2021","unstructured":"Furukawa, T. A. et al. Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data. Lancet Psychiatry 8, 500\u2013511 (2021).","journal-title":"Lancet Psychiatry"},{"key":"454_CR184","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/wps.20151","volume":"13","author":"G Andersson","year":"2014","unstructured":"Andersson, G., Cuijpers, P., Carlbring, P., Riper, H. & Hedman, E. Guided Internet\u2010based vs. face\u2010to\u2010face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta\u2010analysis. World Psychiatry 13, 288\u2013295 (2014).","journal-title":"World Psychiatry"},{"key":"454_CR185","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/jamapsychiatry.2019.0268","volume":"76","author":"P Cuijpers","year":"2019","unstructured":"Cuijpers, P., Noma, H., Karyotaki, E., Cipriani, A. & Furukawa, T. A. Effectiveness and acceptability of cognitive behavior therapy delivery formats in adults with depression: a network meta-analysis. JAMA Psychiatry 76, 700\u2013707 (2019).","journal-title":"JAMA Psychiatry"},{"key":"454_CR186","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.euroneuro.2022.01.002","volume":"57","author":"J Zohar","year":"2022","unstructured":"Zohar, J. & Levy, D. M. Neuroscience-based nomenclature of psychotropics: progress report. Eur. Neuropsychopharmacol. 57, 36\u201338 (2022).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"454_CR187","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.euroneuro.2015.08.019","volume":"25","author":"J Zohar","year":"2015","unstructured":"Zohar, J. et al. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. Eur. Neuropsychopharmacol. 25, 2318\u20132325 (2015). Provides an introduction to Neuroscience-based Nomenclature, a system for standardizing nomenclature of psychiatric medications.","journal-title":"Eur. Neuropsychopharmacol."},{"key":"454_CR188","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","volume":"63","author":"MJ Taylor","year":"2006","unstructured":"Taylor, M. J., Freemantle, N., Geddes, J. R. & Bhagwagar, Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch. Gen. Psychiatry 63, 1217\u20131223 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"454_CR189","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/wps.20941","volume":"21","author":"F Leichsenring","year":"2022","unstructured":"Leichsenring, F., Steinert, C., Rabung, S. & Ioannidis, J. P. A. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry 21, 133\u2013145 (2022). An umbrella review of 102 meta-analyses of RCTs that investigated the effect of psychotherapies and pharmacotherapies for multiple mental disorders.","journal-title":"World Psychiatry"},{"key":"454_CR190","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamapsychiatry.2020.4564","volume":"78","author":"MM Maslej","year":"2021","unstructured":"Maslej, M. M. et al. Individual differences in response to antidepressants: a meta-analysis of placebo-controlled randomized clinical trials. JAMA Psychiatry 78, 490\u2013497 (2021).","journal-title":"JAMA Psychiatry"},{"key":"454_CR191","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1176\/appi.focus.16407","volume":"16","author":"A Cipriani","year":"2018","unstructured":"Cipriani, A. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus 16, 420\u2013429 (2018). This systematic review and meta-analysis compares several antidepressant medications across efficacy, acceptability and tolerability outcomes.","journal-title":"Focus"},{"key":"454_CR192","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/npp.2011.306","volume":"37","author":"J Undurraga","year":"2012","unstructured":"Undurraga, J. & Baldessarini, R. J. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 37, 851\u2013864 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"454_CR193","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/wps.20881","volume":"20","author":"CU Correll","year":"2021","unstructured":"Correll, C. U. et al. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry 20, 244\u2013275 (2021). An umbrella review of 14 network meta-analyses and 90 meta-analyses that investigated the role of several intervention modalities on 15 mental disorders in children and adolescents.","journal-title":"World Psychiatry"},{"key":"454_CR194","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","volume":"7","author":"X Zhou","year":"2020","unstructured":"Zhou, X. et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 7, 581\u2013601 (2020).","journal-title":"Lancet Psychiatry"},{"key":"454_CR195","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1017\/S0033291722001246","volume":"52","author":"Y Yan","year":"2022","unstructured":"Yan, Y. et al. Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis. Psychol. Med. 52, 2224\u20132231 (2022).","journal-title":"Psychol. Med."},{"key":"454_CR196","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/S0140-6736(15)00308-6","volume":"386","author":"EJ Lenze","year":"2015","unstructured":"Lenze, E. J. et al. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet 386, 2404\u20132412 (2015).","journal-title":"Lancet"},{"key":"454_CR197","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJMoa2204462","volume":"388","author":"EJ Lenze","year":"2023","unstructured":"Lenze, E. J. et al. Antidepressant augmentation versus switch in treatment-resistant geriatric depression. N. Engl. J. Med. 388, 1067\u20131079 (2023).","journal-title":"N. Engl. J. Med."},{"key":"454_CR198","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00406-022-01418-4","volume":"273","author":"N Rost","year":"2023","unstructured":"Rost, N., Binder, E. B. & Br\u00fcckl, T. M. Predicting treatment outcome in depression: an introduction into current concepts and challenges. Eur. Arch. Psychiatry Clin. Neurosci. 273, 113\u2013127 (2023).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"454_CR199","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/wps.21078","volume":"22","author":"A Abi\u2010Dargham","year":"2023","unstructured":"Abi\u2010Dargham, A. et al. Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry 22, 236\u2013262 (2023).","journal-title":"World Psychiatry"},{"key":"454_CR200","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpsychires.2017.09.024","volume":"96","author":"P Bradley","year":"2018","unstructured":"Bradley, P. et al. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: a randomized clinical trial demonstrating clinical utility. J. Psychiatr. Res. 96, 100\u2013107 (2018).","journal-title":"J. Psychiatr. Res."},{"key":"454_CR201","doi-asserted-by":"publisher","first-page":"469","DOI":"10.9758\/cpn.2018.16.4.469","volume":"16","author":"C Han","year":"2018","unstructured":"Han, C. et al. A pharmacogenomic-based antidepressant treatment for patients with major depressive disorder: results from an 8-week, randomized, single-blinded clinical trial. Clin. Psychopharmacol. Neurosci. 16, 469 (2018).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"454_CR202","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jama.2022.9805","volume":"328","author":"DW Oslin","year":"2022","unstructured":"Oslin, D. W. et al. Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: the PRIME Care randomized clinical trial. J. Am. Med. Assoc. 328, 151\u2013161 (2022).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR203","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2022.10018","volume":"328","author":"DV Iosifescu","year":"2022","unstructured":"Iosifescu, D. V. Pharmacogenomic testing for next-step antidepressant selection: still a work in progress. J. Am. Med. Assoc. 328, 146\u2013148 (2022).","journal-title":"J. Am. Med. Assoc."},{"key":"454_CR204","unstructured":"Moraczewski, J. & Aedma, K. K. Tricyclic Antidepressants. StatPearls [online] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557791\/ (updated 21 November 2022)."},{"key":"454_CR205","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn, M., Letunic, I., Jensen, L. J. & Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res. 44, D1075\u2013D1079 (2016).","journal-title":"Nucleic Acids Res."},{"key":"454_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01770-w","author":"G Croatto","year":"2022","unstructured":"Croatto, G. et al. The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: an umbrella review of the evidence from randomised controlled trials. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-022-01770-w (2022). This umbrella review included 97 meta-analyses to explore the association between pharmacological and non-pharmacological interventions on physical health outcomes.","journal-title":"Mol. Psychiatry"},{"key":"454_CR207","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2019.2859","volume":"76","author":"E Dragioti","year":"2019","unstructured":"Dragioti, E. et al. Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiatry 76, 1241\u20131255 (2019). An umbrella review of 45 meta-analyses of observational studies that have investigated the association between antidepressant use and adverse health outcomes.","journal-title":"JAMA Psychiatry"},{"key":"454_CR208","unstructured":"Pratt, L. A., Brody, D. J. & Gu, Q. Antidepressant Use in Persons Aged 12 and Over: United States, 2005\u20132008 (US Department of Health and Human Services, Centers for Disease Control, 2011)."},{"key":"454_CR209","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1056\/NEJMoa2106356","volume":"385","author":"G Lewis","year":"2021","unstructured":"Lewis, G. et al. Maintenance or discontinuation of antidepressants in primary care. N. Engl. J. Med. 385, 1257\u20131267 (2021).","journal-title":"N. Engl. J. Med."},{"key":"454_CR210","first-page":"449","volume":"74","author":"CH Warner","year":"2006","unstructured":"Warner, C. H., Bobo, W., Warner, C. M., Reid, S. & Rachal, J. Antidepressant discontinuation syndrome. Am. Fam. Physician 74, 449\u2013456 (2006).","journal-title":"Am. Fam. Physician"},{"key":"454_CR211","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1038\/s41380-022-01524-8","volume":"27","author":"J Hyde","year":"2022","unstructured":"Hyde, J. et al. Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials. Mol. Psychiatry 27, 2709\u20132719 (2022).","journal-title":"Mol. Psychiatry"},{"key":"454_CR212","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJMra2034954","volume":"386","author":"RT Espinoza","year":"2022","unstructured":"Espinoza, R. T. & Kellner, C. H. Electroconvulsive therapy. N. Engl. J. Med. 386, 667\u2013672 (2022).","journal-title":"N. Engl. J. Med."},{"key":"454_CR213","doi-asserted-by":"publisher","first-page":"19907","DOI":"10.4088\/JCP.v65n0406","volume":"65","author":"MM Husain","year":"2004","unstructured":"Husain, M. M. et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J. Clin. Psychiatry 65, 19907 (2004).","journal-title":"J. Clin. Psychiatry"},{"key":"454_CR214","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/acps.12994","volume":"139","author":"A Bahji","year":"2019","unstructured":"Bahji, A., Hawken, E., Sepehry, A., Cabrera, C. & Vazquez, G. ECT beyond unipolar major depression: systematic review and meta\u2010analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr. Scand. 139, 214\u2013226 (2019).","journal-title":"Acta Psychiatr. Scand."},{"key":"454_CR215","first-page":"79","volume":"41","author":"JP Meyer","year":"2018","unstructured":"Meyer, J. P., Swetter, S. K. & Kellner, C. H. Electroconvulsive therapy in geriatric psychiatry: a selective review. Psychiatr. Clin. 41, 79\u201393 (2018).","journal-title":"Psychiatr. Clin."},{"key":"454_CR216","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1176\/foc.6.1.foc155","volume":"6","author":"D Pagnin","year":"2008","unstructured":"Pagnin, D., de Queiroz, V., Pini, S. & Cassano, G. B. Efficacy of ECT in depression: a meta-analytic review. Focus 6, 155\u2013162 (2008).","journal-title":"Focus"},{"key":"454_CR217","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pnpbp.2014.02.004","volume":"51","author":"J Ren","year":"2014","unstructured":"Ren, J. et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis. Prog. Neuro Psychopharmacol. Biol. Psychiatry 51, 181\u2013189 (2014).","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"454_CR218","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1001\/jamapsychiatry.2023.0562","volume":"80","author":"V Menon","year":"2023","unstructured":"Menon, V., Varadharajan, N., Faheem, A. & Andrade, C. Ketamine vs electroconvulsive therapy for major depressive episode: a systematic review and meta-analysis. JAMA Psychiatry 80, 639\u2013642 (2023).","journal-title":"JAMA Psychiatry"},{"key":"454_CR219","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","volume":"388","author":"A Anand","year":"2023","unstructured":"Anand, A. et al. Ketamine versus ECT for nonpsychotic treatment-resistant major depression. N. Engl. J. Med. 388, 2315\u20132325 (2023).","journal-title":"N. Engl. J. Med."},{"key":"454_CR220","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1176\/appi.ajp.2021.20101429","volume":"179","author":"EJ Cole","year":"2022","unstructured":"Cole, E. J. et al. Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial. Am. J. Psychiatry 179, 132\u2013141 (2022).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brs.2016.11.009","volume":"10","author":"G Cirillo","year":"2017","unstructured":"Cirillo, G. et al. Neurobiological after-effects of non-invasive brain stimulation. Brain Stimul. 10, 1\u201318 (2017).","journal-title":"Brain Stimul."},{"key":"454_CR222","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014820","volume":"7","author":"J Krogh","year":"2017","unstructured":"Krogh, J., Hjorth\u00f8j, C., Speyer, H., Gluud, C. & Nordentoft, M. Exercise for patients with major depression: a systematic review with meta-analysis and trial sequential analysis. BMJ Open 7, e014820 (2017).","journal-title":"BMJ Open"},{"key":"454_CR223","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1590\/1516-4446-2016-1915","volume":"38","author":"FB Schuch","year":"2016","unstructured":"Schuch, F. B. et al. Exercise for depression in older adults: a meta-analysis of randomized controlled trials adjusting for publication bias. Braz. J. Psychiatry 38, 247\u2013254 (2016).","journal-title":"Braz. J. Psychiatry"},{"key":"454_CR224","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jad.2015.10.019","volume":"190","author":"B Stubbs","year":"2016","unstructured":"Stubbs, B. et al. Dropout from exercise randomized controlled trials among people with depression: a meta-analysis and meta regression. J. Affect. Disord. 190, 457\u2013466 (2016).","journal-title":"J. Affect. Disord."},{"key":"454_CR225","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","volume":"6","author":"J Firth","year":"2019","unstructured":"Firth, J. et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry 6, 675\u2013712 (2019). Developed by a Lancet Psychiatry Commission Task Force, this publication provides a detailed overview of how the physical health of people with mental disorders can be addressed.","journal-title":"Lancet Psychiatry"},{"key":"454_CR226","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/wps.20701","volume":"19","author":"P Cuijpers","year":"2020","unstructured":"Cuijpers, P. et al. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry 19, 92\u2013107 (2020).","journal-title":"World Psychiatry"},{"key":"454_CR227","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/wps.20089","volume":"13","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers, P. et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 13, 56\u201367 (2014).","journal-title":"World Psychiatry"},{"key":"454_CR228","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1001\/jamapsychiatry.2021.0823","volume":"78","author":"JJF Breedvelt","year":"2021","unstructured":"Breedvelt, J. J. F., Warren, F. C., Segal, Z., Kuyken, W. & Bockting, C. L. Continuation of antidepressants vs sequential psychological interventions to prevent relapse in depression: an individual participant data meta-analysis. JAMA Psychiatry 78, 868\u2013875 (2021).","journal-title":"JAMA Psychiatry"},{"key":"454_CR229","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/15622975.2020.1851052","volume":"22","author":"S Dodd","year":"2021","unstructured":"Dodd, S. et al. A clinical approach to treatment resistance in depressed patients: what to do when the usual treatments don\u2019t work well enough? World J. Biol. Psychiatry 22, 483\u2013494 (2021).","journal-title":"World J. Biol. Psychiatry"},{"key":"454_CR230","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/da.23135","volume":"38","author":"YE Rybak","year":"2021","unstructured":"Rybak, Y. E. et al. Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment. Depress. Anxiety 38, 456\u2013467 (2021).","journal-title":"Depress. Anxiety"},{"key":"454_CR231","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jad.2014.09.020","volume":"171","author":"D Bennabi","year":"2015","unstructured":"Bennabi, D. et al. Risk factors for treatment resistance in unipolar depression: a systematic review. J. Affect. Disord. 171, 137\u2013141 (2015).","journal-title":"J. Affect. Disord."},{"key":"454_CR232","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jad.2011.09.038","volume":"136","author":"LC Barry","year":"2012","unstructured":"Barry, L. C., Abou, J. J., Simen, A. A. & Gill, T. M. Under-treatment of depression in older persons. J. Affect. Disord. 136, 789\u2013796 (2012).","journal-title":"J. Affect. Disord."},{"key":"454_CR233","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","volume":"302","author":"NA Nu\u00f1ez","year":"2022","unstructured":"Nu\u00f1ez, N. A. et al. Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis. J. Affect. Disord. 302, 385\u2013400 (2022).","journal-title":"J. Affect. Disord."},{"key":"454_CR234","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4088\/JCP.19m12928","volume":"80","author":"M Fava","year":"2019","unstructured":"Fava, M. et al. A phase 2, randomized, double-blind, placebo-controlled study of adjunctive pimavanserin in patients with major depressive disorder and an inadequate response to therapy (CLARITY). J. Clin. Psychiatry 80, 481 (2019).","journal-title":"J. Clin. Psychiatry"},{"key":"454_CR235","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.4088\/JCP.19r12889","volume":"81","author":"GI Papakostas","year":"2020","unstructured":"Papakostas, G. I. et al. Efficacy of esketamine augmentation in major depressive disorder: a meta-analysis. J. Clin. Psychiatry 81, 6603 (2020).","journal-title":"J. Clin. Psychiatry"},{"key":"454_CR236","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S2215-0366(19)30394-3","volume":"6","author":"EH Turner","year":"2019","unstructured":"Turner, E. H. Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval. Lancet Psychiatry 6, 977\u2013979 (2019).","journal-title":"Lancet Psychiatry"},{"key":"454_CR237","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","volume":"276","author":"RS McIntyre","year":"2020","unstructured":"McIntyre, R. S. et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis. J. Affect. Disord. 276, 576\u2013584 (2020).","journal-title":"J. Affect. Disord."},{"key":"454_CR238","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0706743720970860","volume":"66","author":"J Swainson","year":"2021","unstructured":"Swainson, J. et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the use of racemic ketamine in adults with major depressive disorder: recommandations du groupe de travail du r\u00e9seau canadien pour les traitements de l\u2019humeur et de l\u2019anxi\u00e9t\u00e9 (canmat) concernant l\u2019utilisation de la k\u00e9tamine rac\u00e9mique chez les adultes souffrant de trouble d\u00e9pressif majeur. Can. J. Psychiatry 66, 113\u2013125 (2021).","journal-title":"Can. J. Psychiatry"},{"key":"454_CR239","first-page":"1","volume":"16","author":"Health Quality Ontario.","year":"2016","unstructured":"Health Quality Ontario. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials. Ont. Health Technol. Assess. Ser. 16, 1\u201366 (2016).","journal-title":"Ont. Health Technol. Assess. Ser."},{"key":"454_CR240","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2021.03.019","volume":"287","author":"H Li","year":"2021","unstructured":"Li, H., Cui, L., Li, J., Liu, Y. & Chen, Y. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials. J. Affect. Disord. 287, 115\u2013124 (2021).","journal-title":"J. Affect. Disord."},{"key":"454_CR241","doi-asserted-by":"publisher","first-page":"152156","DOI":"10.1016\/j.comppsych.2019.152156","volume":"98","author":"JM Bottomley","year":"2020","unstructured":"Bottomley, J. M., LeReun, C., Diamantopoulos, A., Mitchell, S. & Gaynes, B. N. Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: a systematic review and meta-analysis. Compr. Psychiatry 98, 152156 (2020).","journal-title":"Compr. Psychiatry"},{"key":"454_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092796","author":"FL Hitti","year":"2020","unstructured":"Hitti, F. L., Yang, A. I., Cristancho, M. A. & Baltuch, G. H. Deep brain stimulation is effective for treatment-resistant depression: a meta-analysis and meta-regression. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9092796 (2020).","journal-title":"J. Clin. Med."},{"key":"454_CR243","doi-asserted-by":"publisher","first-page":"E178","DOI":"10.1097\/AOG.0000000000003772","volume":"135","author":"[No authors listed.]","year":"2020","unstructured":"[No authors listed.] Physical activity and exercise during pregnancy and the postpartum period: ACOG Committee Opinion, number 804. Obstet. Gynecol. 135, E178\u2013E188 (2020).","journal-title":"Obstet. Gynecol."},{"key":"454_CR244","doi-asserted-by":"publisher","first-page":"114756","DOI":"10.1016\/j.psychres.2022.114756","volume":"316","author":"ZQ Lou","year":"2022","unstructured":"Lou, Z. Q., Zhou, Y. Y., Zhang, X. & Jiang, H. Y. Exposure to selective noradrenalin reuptake inhibitors during the first trimester of pregnancy and risk of congenital malformations: a meta-analysis of cohort studies. Psychiatry Res. 316, 114756 (2022).","journal-title":"Psychiatry Res."},{"key":"454_CR245","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","volume":"392","author":"S Meltzer-Brody","year":"2018","unstructured":"Meltzer-Brody, S. et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet 392, 1058\u20131070 (2018).","journal-title":"Lancet"},{"key":"454_CR246","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12955-021-01883-w","volume":"19","author":"F Van Krugten","year":"2021","unstructured":"Van Krugten, F., Feskens, K., Busschbach, J., Hakkaart-van Roijen, L. & Brouwer, W. Instruments to assess quality of life in people with mental health problems: a systematic review and dimension analysis of generic, domain-and disease-specific instruments. Health Qual. Life Outcomes 19, 249 (2021).","journal-title":"Health Qual. Life Outcomes"},{"key":"454_CR247","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219455","volume":"14","author":"Y Cho","year":"2019","unstructured":"Cho, Y. et al. Factors associated with quality of life in patients with depression: a nationwide population-based study. PLoS ONE 14, e0219455 (2019).","journal-title":"PLoS ONE"},{"key":"454_CR248","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/hup.438","volume":"18","author":"AG Mayers","year":"2003","unstructured":"Mayers, A. G., Van Hooff, J. C. & Baldwin, D. S. Quantifying subjective assessment of sleep and life\u2010quality in antidepressant\u2010treated depressed patients. Hum. Psychopharmacol. Clin. Exp. 18, 21\u201327 (2003).","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"454_CR249","doi-asserted-by":"publisher","first-page":"e1160","DOI":"10.4088\/JCP.11r07586","volume":"73","author":"WR Pigeon","year":"2012","unstructured":"Pigeon, W. R., Pinquart, M. & Conner, K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J. Clin. Psychiatry 73, e1160\u2013e1167 (2012).","journal-title":"J. Clin. Psychiatry"},{"key":"454_CR250","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1017\/S0033291710001911","volume":"41","author":"H Conradi","year":"2011","unstructured":"Conradi, H., Ormel, J. & De Jonge, P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychological Med. 41, 1165\u20131174 (2011).","journal-title":"Psychological Med."},{"key":"454_CR251","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.comppsych.2014.08.051","volume":"56","author":"RS McIntyre","year":"2015","unstructured":"McIntyre, R. S. et al. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Compr. Psychiatry 56, 279\u2013282 (2015).","journal-title":"Compr. Psychiatry"},{"key":"454_CR252","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2215-0366(19)30291-3","volume":"6","author":"M Semkovska","year":"2019","unstructured":"Semkovska, M. et al. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry 6, 851\u2013861 (2019).","journal-title":"Lancet Psychiatry"},{"key":"454_CR253","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ijnp\/pyx070","volume":"21","author":"BT Baune","year":"2018","unstructured":"Baune, B. T., Brignone, M. & Larsen, K. G. A network meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder. Int. J. Neuropsychopharmacol. 21, 97\u2013107 (2018).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"454_CR254","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(19)32316-5","volume":"394","author":"O Plana-Ripoll","year":"2019","unstructured":"Plana-Ripoll, O. et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet 394, 1827\u20131835 (2019).","journal-title":"Lancet"},{"key":"454_CR255","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1192\/bjp.bp.107.039107","volume":"192","author":"J Ormel","year":"2008","unstructured":"Ormel, J. et al. Disability and treatment of specific mental and physical disorders across the world. Br. J. Psychiatry 192, 368\u2013375 (2008).","journal-title":"Br. J. Psychiatry"},{"key":"454_CR256","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12916-018-1101-z","volume":"16","author":"MO Machado","year":"2018","unstructured":"Machado, M. O. et al. The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses. BMC Med. 16, 112 (2018).","journal-title":"BMC Med."},{"key":"454_CR257","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/da.23113","volume":"38","author":"S Saha","year":"2021","unstructured":"Saha, S. et al. Co-morbidity between mood and anxiety disorders: a systematic review and meta-analysis. Depress. Anxiety 38, 286\u2013306 (2021).","journal-title":"Depress. Anxiety"},{"key":"454_CR258","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1177\/00048674211054740","volume":"56","author":"S Saha","year":"2022","unstructured":"Saha, S. et al. Comorbidity between mood and substance-related disorders: a systematic review and meta-analysis. Aust. NZ J. Psychiatry 56, 757\u2013770 (2022).","journal-title":"Aust. NZ J. Psychiatry"},{"key":"454_CR259","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1176\/appi.ajp.2010.09121743","volume":"167","author":"BA Pescosolido","year":"2010","unstructured":"Pescosolido, B. A. et al. \u201cA disease like any other\u201d? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am. J. Psychiatry 167, 1321\u20131330 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"454_CR260","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1192\/bjp.bp.116.189464","volume":"210","author":"N Schnyder","year":"2017","unstructured":"Schnyder, N., Panczak, R., Groth, N. & Schultze-Lutter, F. Association between mental health-related stigma and active help-seeking: systematic review and meta-analysis. Br. J. Psychiatry 210, 261\u2013268 (2017).","journal-title":"Br. J. Psychiatry"},{"key":"454_CR261","doi-asserted-by":"crossref","unstructured":"Eisenberg, D., Golberstein, E. & Hunt, J. B. Mental health and academic success in college. BE J. Economic Anal. Policy 9, 10.2202\/1935-1682.2191 (2009).","DOI":"10.2202\/1935-1682.2191"},{"key":"454_CR262","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaac.2018.07.896","volume":"58","author":"ZM Clayborne","year":"2019","unstructured":"Clayborne, Z. M., Varin, M. & Colman, I. Systematic review and meta-analysis: adolescent depression and long-term psychosocial outcomes. J. Am. Acad. Child Adolesc. Psychiatry 58, 72\u201379 (2019).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"454_CR263","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jad.2018.11.055","volume":"245","author":"K Finning","year":"2019","unstructured":"Finning, K. et al. The association between child and adolescent depression and poor attendance at school: a systematic review and meta-analysis. J. Affect. Disord. 245, 928\u2013938 (2019).","journal-title":"J. Affect. Disord."},{"key":"454_CR264","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/mp.2010.101","volume":"16","author":"J Alonso","year":"2011","unstructured":"Alonso, J. et al. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol. Psychiatry 16, 1234\u20131246 (2011).","journal-title":"Mol. Psychiatry"},{"key":"454_CR265","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S2215-0366(22)00376-5","volume":"10","author":"O Plana-Ripoll","year":"2023","unstructured":"Plana-Ripoll, O. et al. The association between mental disorders and subsequent years of working life: a Danish population-based cohort study. Lancet Psychiatry 10, 30\u201339 (2023). A population-based cohort study that investigated the association between mental disorders and measures of workforce participation in 5,163,321 individuals.","journal-title":"Lancet Psychiatry"},{"key":"454_CR266","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.4088\/JCP.v64n1211","volume":"64","author":"PE Greenberg","year":"2003","unstructured":"Greenberg, P. E. et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J. Clin. Psychiatry 64, 5373 (2003).","journal-title":"J. Clin. Psychiatry"},{"key":"454_CR267","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00127-011-0382-8","volume":"47","author":"SM Chang","year":"2012","unstructured":"Chang, S. M., Hong, J.-P. & Cho, M. J. Economic burden of depression in South Korea. Soc. Psychiatry Psychiatr. Epidemiol. 47, 683\u2013689 (2012).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"454_CR268","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0272-7358(98)00100-7","volume":"20","author":"MC Lovejoy","year":"2000","unstructured":"Lovejoy, M. C., Graczyk, P. A., O\u2019Hare, E. & Neuman, G. Maternal depression and parenting behavior: a meta-analytic review. Clin. Psychol. Rev. 20, 561\u2013592 (2000).","journal-title":"Clin. Psychol. Rev."},{"key":"454_CR269","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1037\/a0014759","volume":"24","author":"MA Whisman","year":"2009","unstructured":"Whisman, M. A. & Uebelacker, L. A. Prospective associations between marital discord and depressive symptoms in middle-aged and older adults. Psychol. Aging 24, 184 (2009).","journal-title":"Psychol. Aging"},{"key":"454_CR270","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/wps.21056","volume":"22","author":"CU Correll","year":"2023","unstructured":"Correll, C. U. et al. The future of psychopharmacology: a critical appraisal of ongoing phase 2\/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents. World Psychiatry 22, 48\u201374 (2023). This publication provides a review of pharmacotherapy interventions currently being trialled and a detailed review of clinical trial considerations relevant to depression research.","journal-title":"World Psychiatry"},{"key":"454_CR271","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","volume":"401","author":"S Marwaha","year":"2023","unstructured":"Marwaha, S. et al. Novel and emerging treatments for major depression. Lancet 401, 141\u2013153 (2023).","journal-title":"Lancet"},{"key":"454_CR272","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","volume":"75","author":"JL Gordon","year":"2018","unstructured":"Gordon, J. L. et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry 75, 149\u2013157 (2018).","journal-title":"JAMA Psychiatry"},{"key":"454_CR273","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","volume":"78","author":"KM Deligiannidis","year":"2021","unstructured":"Deligiannidis, K. M. et al. Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial. JAMA Psychiatry 78, 951\u2013959 (2021).","journal-title":"JAMA Psychiatry"},{"key":"454_CR274","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/npp.2012.58","volume":"37","author":"K Sepanjnia","year":"2012","unstructured":"Sepanjnia, K., Modabbernia, A., Ashrafi, M., Modabbernia, M. J. & Akhondzadeh, S. Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial. Neuropsychopharmacology 37, 2093\u20132100 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"454_CR275","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/15622975.2021.2013041","volume":"23","author":"J Sarris","year":"2022","unstructured":"Sarris, J. et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: the World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J. Biol. Psychiatry 23, 424\u2013455 (2022).","journal-title":"World J. Biol. Psychiatry"},{"key":"454_CR276","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14737175.2022.2083959","volume":"22","author":"L Borrione","year":"2022","unstructured":"Borrione, L. et al. A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavioral therapy for major depression disorders: the PSYLECT study. Expert Rev. Neurother. 22, 513\u2013523 (2022).","journal-title":"Expert Rev. Neurother."},{"key":"454_CR277","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","volume":"227","author":"JD Rosenblat","year":"2018","unstructured":"Rosenblat, J. D. & McIntyre, R. S. Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials. J. Affect. Disord. 227, 219\u2013225 (2018).","journal-title":"J. Affect. Disord."},{"key":"454_CR278","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.2174\/0929867327666200908114902","volume":"28","author":"M El Massry","year":"2021","unstructured":"El Massry, M., Alaeddine, L. M., Ali, L., Saad, C. & Eid, A. A. Metformin: a growing journey from glycemic control to the treatment of Alzheimer\u2019s disease and depression. Curr. Med. Chem. 28, 2328\u20132345 (2021).","journal-title":"Curr. Med. Chem."},{"key":"454_CR279","doi-asserted-by":"publisher","first-page":"702617","DOI":"10.3389\/fpsyt.2021.702617","volume":"12","author":"R De Giorgi","year":"2021","unstructured":"De Giorgi, R. et al. Statins in depression: an evidence-based overview of mechanisms and clinical studies. Front. Psychiatry 12, 702617 (2021).","journal-title":"Front. Psychiatry"},{"key":"454_CR280","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/wps.20481","volume":"17","author":"M Fava","year":"2018","unstructured":"Fava, M. The promise and challenges of drug repurposing in psychiatry. World Psychiatry 17, 28 (2018).","journal-title":"World Psychiatry"},{"key":"454_CR281","doi-asserted-by":"publisher","first-page":"7508","DOI":"10.3390\/ijms23147508","volume":"23","author":"TT Truong","year":"2022","unstructured":"Truong, T. T. et al. Integrative analyses of transcriptomes to explore common molecular effects of antipsychotic drugs. Int. J. Mol. Sci. 23, 7508 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"454_CR282","doi-asserted-by":"publisher","first-page":"873271","DOI":"10.3389\/fphar.2022.873271","volume":"13","author":"TT Truong","year":"2022","unstructured":"Truong, T. T. et al. Co-expression networks unveiled long non-coding RNAs as molecular targets of drugs used to treat bipolar disorder. Front. Pharmacol. 13, 873271 (2022).","journal-title":"Front. Pharmacol."},{"key":"454_CR283","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/YCO.0000000000000759","volume":"35","author":"J Sarris","year":"2022","unstructured":"Sarris, J., Pinzon Rubiano, D., Day, K., Galv\u00e3o-Coelho, N. L. & Perkins, D. Psychedelic medicines for mood disorders: current evidence and clinical considerations. Curr. Opin. Psychiatry 35, 22\u201329 (2022).","journal-title":"Curr. Opin. Psychiatry"},{"key":"454_CR284","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00213-020-05719-1","volume":"238","author":"NL Galv\u00e3o-Coelho","year":"2021","unstructured":"Galv\u00e3o-Coelho, N. L. et al. Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Psychopharmacology 238, 341\u2013354 (2021).","journal-title":"Psychopharmacology"},{"key":"454_CR285","unstructured":"World Health Organization. Comprehensive Mental Health Action Plan 2013\u20132030 (WHO, 2021)."},{"key":"454_CR286","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S2215-0366(17)30096-2","volume":"4","author":"JA Naslund","year":"2017","unstructured":"Naslund, J. A. et al. Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature. Lancet Psychiatry 4, 486\u2013500 (2017).","journal-title":"Lancet Psychiatry"},{"key":"454_CR287","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/wps.20993","volume":"21","author":"CA Espie","year":"2022","unstructured":"Espie, C. A., Firth, J. & Torous, J. Evidence\u2010informed is not enough: digital therapeutics also need to be evidence\u2010based. World Psychiatry 21, 320 (2022).","journal-title":"World Psychiatry"},{"key":"454_CR288","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/eb-2018-102891","volume":"21","author":"J Torous","year":"2018","unstructured":"Torous, J., Nicholas, J., Larsen, M. E., Firth, J. & Christensen, H. Clinical review of user engagement with mental health smartphone apps: evidence, theory and improvements. Evid. Based Ment. Health 21, 116\u2013119 (2018).","journal-title":"Evid. Based Ment. Health"},{"key":"454_CR289","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/bdi.12501","volume":"19","author":"G Parker","year":"2017","unstructured":"Parker, G. et al. Defining melancholia: a core mood disorder. Bipolar Disord. 19, 235\u2013237 (2017).","journal-title":"Bipolar Disord."},{"key":"454_CR290","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","volume":"88","author":"Y Milaneschi","year":"2020","unstructured":"Milaneschi, Y., Lamers, F., Berk, M. & Penninx, B. W. Depression heterogeneity and its biological underpinnings: toward immunometabolic depression. Biol. Psychiatry 88, 369\u2013380 (2020).","journal-title":"Biol. Psychiatry"},{"key":"454_CR291","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biopsych.2020.01.012","volume":"88","author":"CJ Lynch","year":"2020","unstructured":"Lynch, C. J., Gunning, F. M. & Liston, C. Causes and consequences of diagnostic heterogeneity in depression: paths to discovering novel biological depression subtypes. Biol. Psychiatry 88, 83\u201394 (2020).","journal-title":"Biol. Psychiatry"},{"key":"454_CR292","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF02098865","volume":"2","author":"S Glen","year":"1993","unstructured":"Glen, S., Simpson, A., Drinnan, D., McGuinness, D. & Sandberg, S. Testing the reliability of a new measure of life events and experiences in childhood: the psychosocial assessment of childhood experiences (PACE). Eur. Child. Adolesc. Psychiatry 2, 98\u2013110 (1993).","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"454_CR293","doi-asserted-by":"crossref","unstructured":"McGorry, P. D. & Hickie, I. B. Clinical Staging in Psychiatry (Cambridge Univ. Press, 2019).","DOI":"10.1017\/9781139839518"},{"key":"454_CR294","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/wps.20882","volume":"20","author":"AM Chekroud","year":"2021","unstructured":"Chekroud, A. M. et al. The promise of machine learning in predicting treatment outcomes in psychiatry. World Psychiatry 20, 154\u2013170 (2021).","journal-title":"World Psychiatry"},{"key":"454_CR295","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-018-1696-9","volume":"18","author":"S Tomitaka","year":"2018","unstructured":"Tomitaka, S. et al. Distributional patterns of item responses and total scores on the PHQ-9 in the general population: data from the National Health and Nutrition Examination Survey. BMC Psychiatry 18, 108 (2018).","journal-title":"BMC Psychiatry"},{"key":"454_CR296","doi-asserted-by":"publisher","first-page":"342","DOI":"10.7326\/M15-2259","volume":"164","author":"V Forman-Hoffman","year":"2016","unstructured":"Forman-Hoffman, V. et al. Screening for major depressive disorder in children and adolescents: a systematic review for the US Preventive Services Task Force. Ann. Intern. Med. 164, 342\u2013349 (2016).","journal-title":"Ann. Intern. Med."},{"key":"454_CR297","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaac.2022.10.001","volume":"62","author":"HJ Walter","year":"2023","unstructured":"Walter, H. J. et al. Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders. J. Am. Acad. Child Adolesc. Psychiatry 62, 479\u2013502 (2023).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"454_CR298","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/archdischild-2022-323822","volume":"107","author":"R Luxton","year":"2022","unstructured":"Luxton, R. & Kyriakopoulos, M. Depression in children and young people: identification and management NICE guidelines. Arch. Dis. Child. Educ. Pract. 107, 36\u201338 (2022).","journal-title":"Arch. Dis. Child. Educ. Pract."},{"key":"454_CR299","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jcpp.13202","volume":"61","author":"JB Dwyer","year":"2020","unstructured":"Dwyer, J. B., Stringaris, A., Brent, D. A. & Bloch, M. H. Annual research review: defining and treating pediatric treatment\u2010resistant depression. J. Child. Psychol. Psychiatry 61, 312\u2013332 (2020).","journal-title":"J. Child. Psychol. Psychiatry"}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00454-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T16:00:21Z","timestamp":1703001621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00454-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":299,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1038\/s41572-023-00454-1","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"11 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S. has received honoraria from and has been a consultant for AbbVie,\u00a0Angelini, Lundbeck and Otsuka. M.B. has received grant and research support from the National Health and Medical Research Council, Wellcome Trust, Medical Research Future Fund, Victorian Medical Research Acceleration Fund, Centre for Research Excellence CRE, Victorian Government Department of Jobs, Precincts and Regions and Victorian COVID-19 Research Fund. He received honoraria from Springer, Oxford University Press, Cambridge University Press, Allen and Unwin, Lundbeck, Controversias Barcelona, Servier, Medisquire, HealthEd, ANZJP, EPA, Janssen, Medplan, Milken Institute, RANZCP, Abbott India, ASCP, Headspace and Sandoz (last 3 years). W.M. has received funding and\/or has attended events funded by Cobram Estate Pty. Ltd and Bega Dairy and Drinks Pty Ltd. W.M. has received consultancy funding from Nutrition Research Australia and ParachuteBH. B.W.J.H.P. has received research grants from Boehringer-Ingelheim and Jansen and received consultancy funding from Angelini and Ekademeia Psychiatry. T.A.F. reports personal fees from Boehringer-Ingelheim, DT Axis, Kyoto University Original, Shionogi and SONY, and a grant from Shionogi, outside the submitted work. In addition, T.A.F. has patents 2020-548587 and 2022-082495 pending, and intellectual properties for Kokoro-app licensed to Mitsubishi-Tanabe. J.F. has received honoraria or consultancy fees from Atheneum, Informa, Gillian Kenny Associates, Big Health, Wood For Trees, Nutritional Medicine Institute, Angelini, ParachuteBH, Richmond Foundation and Nirakara, independent of this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}